SUMMARY: Dr. Shannon Verrett, a retired HISD administrator, discusses issues surrounding the dismissal and discipline of HISD administrators under the Mike Miles Administration. She highlights a growing trend of administrators being removed for advocating for students and teachers, describing the leadership as dictatorial and lacking due process for those terminated. Verrett criticizes contracts that prevent administrators from contesting their removal, deeming them controversial. She emphasizes the need for the administration to reconnect with the community and advocates for teachers and administrators to join support organizations. Verrett expresses concerns about the district’s regression, particularly in special education and academics.

The recent news of an HISD Principal on administrative leave, has now raised the question about school districts and the administrative process. Dr. Shannon Verrett tells us about the steps a school district can take before firing or disciplining administrators.

Source

SUMMARY: Israeli leaders and U.S. Sen. Ted Cruz criticized the Biden administration’s approach to the ongoing Middle East conflict during a Dallas event marking the one-year anniversary of the October 7 terrorist attack. Cruz condemned a State Department tweet urging Israel not to retaliate, calling it “disgraceful.” Another tweet by Secretary of State Antony Blinken echoed this sentiment. Cruz emphasized the need for Israel to eliminate Hamas and Hezbollah, funded by Iran, highlighting the threat they pose. Israeli Prime Minister Netanyahu asserted Israel’s commitment to defend itself on multiple fronts, urging global support against terrorism. Biden reinforced U.S. support for Israel’s security amid the conflict.

Read the full article

The post Israel leaders, Cruz push back on Biden administration response to Israel attack | Texas appeared first on www.thecentersquare.com

SUMMARY: Rice University is collaborating on a groundbreaking implant designed to enhance medication adherence for obesity and type 2 diabetes drugs, potentially lowering costs. The implant, called Rogue, is finger-tip sized and acts as an on-demand drug delivery system, aiming to reduce annual costs to under $11,000. Developed by researcher Omid Vasa, this minimally invasive device communicates with a smartphone app, allowing for precise control of dosing without the need for frequent injections. The implant could remain effective for a year, significantly simplifying drug management and improving accessibility for patients, while also addressing the rising costs of current therapies.

Rice University is part of a research team developing an implant designed to improve adherence to obesity and type 2 diabetes drugs.

Source